Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
USD 10.61
(-0.28%)
USD 10.61
(-0.28%)
| Breakdown | 2023 |
|---|---|
| Operating Cash Flow | - |
| Net Income | 171.38 Thousand |
| Depreciation & Amortization | - |
| Deferred income taxes | - |
| Stock-based compensation | - |
| Change in working capital | 24.84 Thousand |
| Other non-cash items | -196.23 Thousand |
| Investing Cash Flow | -69.69 Million |
| Investments in PPE | - |
| Acquisitions | - |
| Investment purchases | -69.69 Million |
| Sales/Maturities of investments | - |
| Other Investing Activities | - |
| Financing Cash Flow | 70.27 Million |
| Debt repayment | -3618.00 |
| Dividends payments | - |
| Common Stock Repurchased | - |
| Common Stock Issuance | 70.27 Million |
| Other Financing Activities | - |
| Accounts receivables | - |
| Accounts payables | - |
| Inventory | - |
| Other working capital | 24.84 Thousand |
| Cash at beginning of period | - |
| Cash at end of period | 580.71 Thousand |
| Capital Expenditure | - |
| Effect of forex changes on cash | - |
| Net cash flow / Change in cash | 580.71 Thousand |
| Free Cash Flow | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - |
| Net Income | 609.09 Thousand | 755.5 Thousand | 171.38 Thousand | 175 Thousand |
| Depreciation & Amortization | - | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 52.87 Thousand | -13.33 Thousand | 24.84 Thousand | 24.84 Thousand |
| Other non-cash items | -918.2 Thousand | -908.83 Thousand | -196.23 Thousand | -196.23 Thousand |
| Investing Cash Flow | - | - | -69.69 Million | -69.69 Million |
| Investments in PPE | - | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | -69.69 Million | -69.69 Million |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | - | - | 70.27 Million | 70.25 Million |
| Debt repayment | - | - | -3618.00 | -7236.00 |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | 70.27 Million | 70.26 Million |
| Other Financing Activities | - | - | - | - |
| Accounts receivables | - | -302.00 | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | 52.57 Thousand | -13.03 Thousand | 24.84 Thousand | - |
| Cash at beginning of period | 413.74 Thousand | 580.71 Thousand | - | 10 Thousand |
| Cash at end of period | 157.5 Thousand | 413.74 Thousand | 580.71 Thousand | 580.71 Thousand |
| Capital Expenditure | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -256.24 Thousand | -166.97 Thousand | 580.71 Thousand | 570.71 Thousand |
| Free Cash Flow | -256.24 Thousand | -166.97 Thousand | - | 3618.00 |
REJL-B
CORE-D
AGDY
MEL
0731
000639